Genmab A/S

Genmab A/Sverified

GE9.F

Price:

$264.9

Market Cap:

$124.06B

Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; and Amivantamab for advanced or metastatic gastric or esophageal cancer and NSCLC. Its products include daratumumab to treat MM, non-MM blood cancers, and AL amyloidosis; GEN1047; tisotumab vedotin for treating cervical, ovarian, and solid cancers; DuoBody-PD-L1x4-1BB, and DuoBody-CD40x4-1BB for treating solid tumors; Epcoritamab for relapsed/refractory diffuse large B-cell lymphoma and chronic lymphocytic leukemia...[Read more]

Industry

Medical - Pharmaceuticals

IPO Date

2000-10-23

Stock Exchange

FSX

Ticker

GE9.F

The Enterprise Value as of December 2025 (TTM) for Genmab A/S (GE9.F) is 116.76B

According to Genmab A/S’s latest financial reports and current stock price. The company's current Enterprise Value is 116.76B. This represents a change of 40.15% compared to the average of 83.31B of the last 4 quarters.

Genmab A/S (GE9.F) Historical Enterprise Value (quarterly & annually)

How has GE9.F Enterprise Value performed in the past?

The mean historical Enterprise Value of Genmab A/S over the last ten years is 105.22B. The current 116.76B Enterprise Value has changed 11.00% with respect to the historical average. Over the past ten years (40 quarters), GE9.F's Enterprise Value was at its highest in in the December 2022 quarter at 182.96B. The Enterprise Value was at its lowest in in the September 2015 quarter at 35.46B.

Quarterly (TTM)
Annual

Average

105.22B

Median

88.77B

Minimum

52.82B

Maximum

183.01B

Genmab A/S (GE9.F) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Genmab A/S Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 165.00%

Maximum Annual Enterprise Value = 183.01B

Minimum Annual Increase = -30.80%

Minimum Annual Enterprise Value = 52.82B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202487.64B-30.80%
2023126.65B-30.80%
2022183.01B11.96%
2021163.46B6.42%
2020153.59B70.83%
201989.91B44.46%
201862.24B-1.24%
201763.01B-9.89%
201669.93B32.39%
201552.82B165.00%

Genmab A/S (GE9.F) Average Enterprise Value

How has GE9.F Enterprise Value performed in the past?

The current Enterprise Value of Genmab A/S (GE9.F) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

132.43B

5-year avg

142.87B

10-year avg

105.22B

Genmab A/S (GE9.F) Enterprise Value vs. Peers

How is GE9.F’s Enterprise Value compared to its peers?

Genmab A/S’s Enterprise Value is less than Coloplast A/S (150.61B), greater than Biogen Inc. (28.26B), greater than Fresenius Medical Care AG & Co. KGaA (20.98B), greater than BioNTech SE (9.37B), greater than Sartorius AG (20.61B), greater than Sartorius AG (20.61B), greater than Illumina, Inc. (22.13B), greater than Koninklijke Philips N.V. (28.22B), greater than Elanco Animal Health Inc (14.38B), greater than Qiagen N.V. (10.58B),

Build a custom stock screener for Genmab A/S (GE9.F) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genmab A/S using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Genmab A/S (GE9.F) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Genmab A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Genmab A/S's Enterprise Value?

What is the highest Enterprise Value for Genmab A/S (GE9.F)?

What is the 3-year average Enterprise Value for Genmab A/S (GE9.F)?

What is the 5-year average Enterprise Value for Genmab A/S (GE9.F)?

How does the current Enterprise Value for Genmab A/S (GE9.F) compare to its historical average?